XTX Topco Ltd Acquires Shares of 51,591 Sotera Health Company (NASDAQ:SHC)

Key Points

• XTX Topco Ltd has made a new investment of approximately $602,000 in Sotera Health Company, acquiring 51,591 shares during the first quarter.
• Several hedge funds have recently increased their stakes in Sotera Health, demonstrating strong institutional interest with 91.03% of the stock owned by institutional investors.
• Wall Street analysts have varying ratings on Sotera Health, with Goldman Sachs upgrading it from "neutral" to "buy" and setting a new target price of $17.00.

XTX Topco Ltd purchased a new stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 51,591 shares of the company's stock, valued at approximately $602,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Quarry LP acquired a new stake in shares of Sotera Health in the fourth quarter valued at $28,000. Tower Research Capital LLC TRC grew its stake in shares of Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after buying an additional 6,200 shares in the last quarter. Sterling Capital Management LLC grew its position in Sotera Health by 58.5% in the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after buying an additional 3,331 shares during the last quarter. Finally, Corton Capital Inc. acquired a new position in Sotera Health in the fourth quarter worth approximately $139,000. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Performance

Sotera Health stock traded up $2.75 during midday trading on Friday, reaching $13.97. 4,336,946 shares of the company's stock were exchanged, compared to its average volume of 1,037,193. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $17.08. The company has a debt-to-equity ratio of 5.55, a quick ratio of 2.19 and a current ratio of 2.46. The firm has a market cap of $3.97 billion, a price-to-earnings ratio of 174.65 and a beta of 1.81. The stock's 50-day simple moving average is $11.63 and its 200 day simple moving average is $12.04.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. The company had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.19 earnings per share. On average, analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently weighed in on SHC. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a research note on Friday. Wall Street Zen upgraded shares of Sotera Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Finally, Piper Sandler cut their price objective on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.